W. Ray Kim

TL;DR: The Model for End‐stage Liver Disease was initially created to predict survival in patients with complications of portal hypertension undergoing elective placement of transjugular intrahepatic portosystemic shunts and was validated subsequently as an accurate predictor of survival among different populations of patients with advanced liver disease.

TL;DR: This population-wide study shows that the MELD score and the serum sodium concentration are important predictors of survival among candidates for liver transplantation.

TL;DR: A number of guidelines were established for creating an index of disease severity to estimate survival in patients with chronic liver disease and it was determined that such a disease severity index should rely on a few, readily available, objective variables that would be generally applicable to a heterogeneous group of patients with end-stage liver disease.

TL;DR: The prevalence of undiagnosed CD seems to have increased dramatically in the United States during the past 50 years and is associated with a nearly 4-fold increased risk of death.

TL;DR: This document presents the official position of the American Association for the Study of Liver Diseases on the application of serum alanine aminotransferase (AL T) activity, based upon an analysis of the currently available scientific data.